London 2012 partner, GlaxoSmithKline, shares scientific expertise with World Anti-Doping Agency
|
05 July 2011 |
GSK to purchase Shenzhen Neptunus stake in previously formed joint venture for influenza vaccines in China
|
15 June 2011 |
GlaxoSmithKline and Valeant announce US FDA approval of Potiga™ (ezogabine)
|
13 June 2011 |
Millions of children in the world's poorest countries could receive vaccination against rotavirus diarrhoeal disease
|
09 June 2011 |
GSK forms partnership with three leading NGOs
|
25 May 2011 |
Pharmaceutical industry and university create Manchester Collaborative Centre for Inflammation Research
|
12 May 2011 |
GSK welcomes key agreement to support global preparedness against pandemic influenza
|
19 April 2011 |
GSK publishes payments for research, consulting and advising by US healthcare professionals
|
01 April 2011 |
GSK statement on Avodart™ (dutasteride) for prostate cancer risk reduction
|
28 March 2011 |
GSK supports recovery efforts to help those affected by the Japan earthquake
|
20 March 2011 |